Vivanza Biosciences consolidated net profit declines 92.31% in the September 2024 quarter

Sales decline 60.63% to Rs 3.00 crore
Net profit of Vivanza Biosciences declined 92.31% to Rs 0.02 crore in the quarter ended September 2024 as against Rs 0.26 crore during the previous quarter ended September 2023. Sales declined 60.63% to Rs 3.00 crore in the quarter ended September 2024 as against Rs 7.62 crore during the previous quarter ended September 2023. ParticularsQuarter EndedSep. 2024Sep. 2023% Var.Sales3.007.62 -61 OPM %3.674.20 -PBDT0.020.26 -92 PBT0.020.26 -92 NP0.020.26 -92Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content
More From This Section
Don't miss the most important news and views of the day. Get them on our Telegram channel
First Published: Oct 18 2024 | 7:32 AM IST
